Subcellular creatine kinase alterations. Implications in heart failure

E De Sousa1, V Veksler, A Minajeva

  • 1Cardiologie Cellulaire et Moléculaire, U-446 INSERM, Faculté de Pharmacie, Université Paris-Sud, Châtenay-Malabry, France.

Circulation Research
|July 13, 1999
PubMed

Insights

Decreased creatine kinase (CK) function in heart failure impairs energy supply and calcium handling. This study in rats reveals altered CK activity contributes to energy flux and calcium homeostasis changes in congestive heart failure.

Area of Science:

  • Biochemistry
  • Cardiology
  • Physiology

Background:

  • Congestive heart failure (CHF) involves complex metabolic and functional changes.
  • Creatine kinase (CK) plays a crucial role in cellular energy buffering and transport.

Purpose of the Study:

  • To investigate the role of creatine kinase (CK) functioning in energy metabolism and calcium homeostasis in a rat model of congestive heart failure (CHF).

Main Methods:

  • Induction of heart failure via aortic banding in young rats.
  • In situ analysis of myofilaments, sarcoplasmic reticulum (SR), and mitochondrial functions using selective membrane permeabilization.
  • Assessment of CK activity, content (Western blots), and compartmentation in cardiac fibers.

Main Results:

  • Significant reduction in mitochondrial CK activity and content, and M-isoform CK (MM-CK) activity in failing hearts.
  • Decreased myofibrillar force and crossbridge kinetics, with unaltered calcium sensitivity.
  • Impaired SR calcium uptake capacity and reduced efficiency of phosphocreatine in enhancing uptake.
  • Diminished myocardial oxidative capacity and impaired respiratory control by adenine nucleotides.

Conclusions:

  • Alterations in CK compartmentation, particularly mitochondrial CK, are evident in CHF.
  • These CK changes contribute to impaired energy fluxes and disrupted calcium homeostasis in the failing heart.
  • Findings highlight CK's role in cardiac energy dynamics and suggest therapeutic targets for heart failure.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...